2001
DOI: 10.1006/abio.2001.4997
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of Hemoglobin Synthesis Rate in Vivo Using a Stable Isotope Method

Abstract: We developed a method to measure hemoglobin synthesis rate (SynHb) in humans, assuming that free glycine in the red blood cell (RBC) represents free glycine in bone marrow for hemoglobin synthesis. The present rat study examines this assumption of the method and quantifies SynHb in rats. Sprague-Dawley rats (n = 9) were studied, [2-13 C]glycine was intravenously infused over 24 h (2.5 mg kg −1 h −1 ), blood was drawn for glycine and heme isolation, and bone marrow was harvested for glycine isolation. Isotopic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(8 citation statements)
references
References 17 publications
0
8
0
Order By: Relevance
“…We first confirmed a dose and dosing schedule for 15 N-or 13 C-glycine based on previous experience [21,32,33]. In the first subject, there was significant enrichment of %APE for both 15 N and 13 C after simultaneous oral ingestion of equal amounts of 15 N-glycine and 13 Cglycine (2 g divided into 3 hourly doses), with no apparent advantage for the more expensive 13 C-glycine.…”
Section: Dose and Dosing Schedulementioning
confidence: 58%
See 1 more Smart Citation
“…We first confirmed a dose and dosing schedule for 15 N-or 13 C-glycine based on previous experience [21,32,33]. In the first subject, there was significant enrichment of %APE for both 15 N and 13 C after simultaneous oral ingestion of equal amounts of 15 N-glycine and 13 Cglycine (2 g divided into 3 hourly doses), with no apparent advantage for the more expensive 13 C-glycine.…”
Section: Dose and Dosing Schedulementioning
confidence: 58%
“…Examples of this approach include the standard radioactive clinical label, 51 Cr [19], and the more precise research label, biotin [20]. In contrast, the use of a metabolic precursor that can be administered orally and biosynthetically incorporated into heme results in a cohort label [21]. Since no ex vivo labeling is required, there are no associated laboratory costs for labeling, no possibility of error in the identification of material for re-infusion, and no potential for bacterial contamination.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, in a fasting state condition, it is difficult to hypothesize different distributions of natural isotopic enrichments of precursors in separate cell types. Moreover, background glycine isotopic enrichments in circulating erythrocytes were previously demonstrated, in animals, to approximate enrichments measured in other tissues (bone marrow) (Hibbert et al 2001). Moreover, the use of background enrichment of blood protein to assess muscle protein turnover has been directly validated in humans (Heys et al 1990).…”
Section: Methodsmentioning
confidence: 84%
“…Whole-body leucine kinetics were measured by simultaneous administration of [1][2][3][4][5][6][7][8][9][10][11][12][13] (19). Two intravenous catheters were placed in opposite arms, one for infusion of labeled compounds and the other for blood sampling.…”
Section: Experimental Protocolmentioning
confidence: 99%
“…Hb Measurements-Glycine was isolated, and derivative enrichment was measured (Metabolic Solutions, Inc) as described previously (19). Heme was extracted from hemolyzed red cells by a previously described method (20).…”
Section: Sample Analysesmentioning
confidence: 99%